MedTrace Logo

Post-Market Study of The Tripod-Fix Vertebral Body Augmentation System in Osteoporotic Vertebral Compression Fractures

NCT06270173 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 53

Last updated 2025-01-22

No results posted yet for this study

Summary

The objective of this Post-Market Clinical Follow-Up Study is to evaluate the safety and performance of the Tripod-Fix in the treatment of vertebral compression fractures (VCF) resulting from osteoporosis.

Conditions

  • Osteoporotic Vertebral Compression Fractures

Interventions

DEVICE

Tripod-Fix Vertebral Body Augmentation System (Tripod-Fix)

The Tripod-Fix is a permanent implant used for vertebral augmentation in patients with osteoporotic vertebral compression fractures.

Sponsors & Collaborators

  • Avania

    collaborator INDUSTRY

  • Wiltrom Co., Ltd.

    lead INDUSTRY

Principal Investigators

  • Te-Yang Tsai · Wiltrom Co., Ltd.

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-02-16
Primary Completion
2025-12-31
Completion
2026-02-28

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06270173 on ClinicalTrials.gov